Logo

Myriad Genetics: Adam Brufsky

May 31, 2023

Myriad Genetics named Adam Brufsky as scientific advisor to its oncology business unit. Brufsky is a board-certified physician in internal medicine and medical oncology and a professor of medicine at the University of Pittsburgh School of Medicine. He earned his medical and PhD degrees from the University of Connecticut School of Medicine, completed an internal medicine residency at Harvard Medical School's Brigham and Women's Hospital, and completed a medical oncology fellowship at the Dana-Farber Cancer Institute.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.